Definition
Subcutaneous injection is the most common administration route referenced across peptide profiles on TruthTides. Peptides typically administered subcutaneously include BPC-157 (near the injury site), Ipamorelin (before sleep or morning), CJC-1295 (1-2 times per week), Sermorelin (daily before bedtime), Semaglutide (weekly as Ozempic/Wegovy), Tirzepatide (weekly), Tesamorelin (daily in the abdominal area), PT-141 (as needed), and AOD-9604 (in the abdominal area).
Source: Administration sections across all peptide FAQs
Related Peptides
BPC-157
View clinical reference page
Ipamorelin
View clinical reference page
CJC-1295
View clinical reference page
Sermorelin
View clinical reference page
Semaglutide
View clinical reference page
Tirzepatide
View clinical reference page
Tesamorelin
View clinical reference page
PT-141 (Bremelanotide)
View clinical reference page
AOD-9604
View clinical reference page